Lyme disease in central Europe

Current Opinion in Infectious Diseases

Volumn 14, Issue 2, 2001, Pages 133-137

  Hercogova, J ^a   Brzonova, I ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; DECORIN; DOXYCYCLINE; LYME DISEASE VACCINE; MINOCYCLINE; OUTER MEMBRANE PROTEIN; PENICILLIN G; PENICILLIN V;

ALOPECIA; ANTIBIOTIC THERAPY; B CELL LYMPHOMA; BORRELIA BURGDORFERI; CELLULAR IMMUNITY; DISEASE ASSOCIATION; DISEASE COURSE; ERYTHEMA CHRONICUM MIGRANS; EUROPE; HUMAN; IXODES; LYME DISEASE; PHOTOPHOBIA; PREGNANCY; RETINA VASCULITIS; REVIEW;

EID: 0035081020     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200104000-00004     Document Type: Review

References (42)

1. Chronic Lyme disease: The debate goes on
2. Characterization of Borrelia burgdorferi sensu lato strains isolated from patients with skin manifestations of Lyme borreliosis residing in Slovenia
3. Lyme disease
4. Lyme borreliosis
5. Impact of climatic change on the northern latitude limit and population density of the disease-transmitting European tick Ixodes ricinus
6. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease
7. Three species of Borrelia burgdorferi sensu lato (Borrelia burgdorferi sensu lato, B. afzelii, and B. garinii) identified from cerebrospinal fluid isolates by pulsed field gel electrophoresis and PCR
8. Genetic analysis of Borrelia garinii OspA serotype 4 strains associated with neuroborreliosis: Evidence for extensive genetic homogeneity
9. Cutting edge: T cell-mediated pathology in murine Lyme borreliosis
10. H1 associated cross reactive idiotype expression in patients with Lyme arthritis and neuroborreliosis
11. Comparative genome analysis of the pathogenic spirochetes Borrelia burgdorferi and Treponema pallidum
12. The expanding clinical spectrum of ocular lyme borreliosis
13. Has the presence or absence of Borrelia burgdorferi sensu lato as detected by skin culture any influence on the course of erythema migrans?
14. Diffuse reversible alopecia in patients with Lyme meningitis and tick/borne encephalitis
15. PCR detected Borrelia burgdorferi DNA in a tissue sample in pseudopelade Brocq
16. Is morphoea caused by Borrelia burgdorferi? A review
17. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma
18. Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin
19. Erythema migrans in pregnancy
20. Facial palsy caused by Borrelia infection in a twin pregnancy in an area of nonendemicity
21. Human granulocytic ehrlichiosis in western Europe
22. Thrombocytopenia and Borrelia burgdofferi: An association remains unproven
23. Acquisition of coinfection and simultaneous transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis ticks
24. Diagnostics of Lyme borreliosis
25. Role of serology in the diagnosis of Lyme disease
26. A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis
27. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE
28. Lyme disease serology: Problems and opportunities
29. Failure of treatment with cephalexine for Lyme disease
30. Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans
31. Minocycline versus doxycycline in the treatment of Lyme neuroborreliosis
32. Adverse effects of minocycline versus doxycycline in the treatment of Lyme neuroborreliosis
33. Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis
34. Long-term outcomes of persons with Lyme disease
35. Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease
36. The outcome of Lyme borreliosis in children
37. Erythema migrans in the immunocompromised host
38. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three Borrelia species
39. Efficacy of antibiotic prophylaxis for prevention of Lyme disease
40. Lyme disease prevention and vaccine prophylaxis
41. Vaccination against Lyme borreliosis
42. Conformational nature of the Borrelia burgdorferi B31 outer surface protein C protective epitope